Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XPO1 | O14980 | 2/20 | 0.41 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 4/20 | 0.37 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 3/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
| ▸ | NOS1 | P29475 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28801096 | 0.78 | BACE1 (0.36) | BACE1CYP2A6LMNAHSP90AA1MAPT | |
| SCHEMBL339928 | 0.77 | BACE1 (0.63) | ARBACE1CYP1A2CYP2A6LMNA | |
| SCHEMBL29683992 | 0.77 | SLC40A1 (0.45) | XPO1ARBACE1CYP1A2CYP2A6 | |
| SCHEMBL845037 | 0.77 | SLC40A1 (0.45) | XPO1ARBACE1CYP1A2CYP2A6 | |
| SCHEMBL30657716 | 0.77 | BACE1 (0.63) | ARBACE1CYP1A2CYP2A6LMNA | |
| SCHEMBL57528 | 0.75 | CCR1 (0.43) | BACE1CYP2A6LMNAHSP90AA1MAPT | |
| SCHEMBL23548885 | 0.74 | XPO1 (0.41) | XPO1ARCYP1A2CYP2A6LMNA | |
| SCHEMBL2757274 | 0.74 | METAP2 (0.59) | XPO1ARCYP1A2AGTR1MAPT | |
| SCHEMBL22119746 | 0.74 | BACE1 (0.48) | BACE1CYP1A2LMNAPDE10AKMT2A | |
| SCHEMBL934781 | 0.74 | KMT2A (0.42) | XPO1ARCYP1A2CYP2A6LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036808-A | Organic electroluminescent material and device | 环球展览公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260136752-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-05-14 | — | — | US | disclosed |
| WO-2024049929-A2 | PANNEXIN-1 MODULATORS AND METHODS OF TREATING DISORDERS IN WHICH PANNEXIN-1 IS IMPLICATED | PANNEX THERAPEUTICS INC. (US) | 2024-03-07 | — | — | WO | disclosed |
| US-11198745-B2 | Poly(alpha-olefin)s and methods thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-12-14 | — | — | US | disclosed |
| EP-3887414-A1 | POLY(ALPHA-OLEFIN)S AND METHODS THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2021-10-06 | — | — | EP | disclosed |
| US-20200190236-A1 | Poly(alpha-olefin)s and Methods Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2020-06-18 | — | — | US | disclosed |
| WO-2020112547-A1 | POLY(ALPHA-OLEFIN)S AND METHODS THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-06-04 | — | — | WO | disclosed |
| CN-109475530-A | For treating the aminoacyl indazole immunomodulator of autoimmune disease | 洛克菲勒大学 | 2019-03-15 | — | — | CN | disclosed |
| CN-108699032-A | Polycyclic T L R7/8 antagonists and their use in treating immune disorders | 默克专利有限公司 | 2018-10-23 | — | — | CN | disclosed |
| CN-108558873-A | A kind of aromatic amine derivant and its organic electroluminescence device | 长春海谱润斯科技有限公司 | 2018-09-21 | — | — | CN | disclosed |
| CN-102249996-B | 2-(quinoline-8-yl)carbonyl-cyclohexane-1,3-dione compounds | BEIJING FAGAIYIN TECHNOLOGY CO LTD | 2012-11-14 | — | — | CN | disclosed |
| CN-102249996-A | 2-(quinoline-8-yl)carbonyl-cyclohexane-1,3-dione compounds | BEIJING FAGAIYIN TECHNOLOGY CO LTD | 2011-11-23 | — | — | CN | disclosed |
| US-7576098-B2 | Heterocyclic compounds as inhibitors of factor VIIa | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-08-18 | — | — | US | disclosed |
| US-7576098-B2 | Heterocyclic compounds as inhibitors of factor VIIa | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-08-18 | — | — | US | disclosed |
| US-7576098-B2 | Heterocyclic compounds as inhibitors of factor VIIa | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-08-18 | — | — | US | disclosed |
| EP-1828152-B1 | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF FACTOR VIIA | BRISTOL MYERS SQUIBB CO (US) | 2008-08-20 | — | — | EP | disclosed |
| EP-1828152-B1 | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF FACTOR VIIA | BRISTOL MYERS SQUIBB CO (US) | 2008-08-20 | — | — | EP | disclosed |
| EP-1828152-A2 | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF FACTOR VIIA | Bristol-Myers Squibb Company (US) | 2007-09-05 | — | — | EP | disclosed |
| US-20060211720-A1 | Heterocyclic compounds as inhibitors of factor VIIa | BRISTOL-MYERS SQUIBB COMPANY | 2006-09-21 | — | — | US | disclosed |
| WO-2006062972-A2 | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF FACTOR VIIA | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-06-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200190236-A1 | Poly(alpha-olefin)s and Methods Thereof | PUF60, DEGS1, POLL | XPO1 4306/4885AR 3349/4885BACE1 777/4885 |
| US-11198745-B2 | Poly(alpha-olefin)s and methods thereof | PUF60, DEGS1, POLL | XPO1 4306/4885AR 3349/4885BACE1 777/4885 |
| US-20260136752-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, GLRB, GLRA1 | XPO1 2398/4885AR 196/4885BACE1 2180/4885 |
| US-20060211720-A1 | Heterocyclic compounds as inhibitors of factor VIIa | TFPI, F7, HABP2 | XPO1 1328/4885AR 3551/4885BACE1 232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.